CopyMark Law Group
4.9/5
Drawing for XLENTI

USPTO serial 98659503

XLENTI

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KOPENSKI, CLAUDIA ANN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with XLENTI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joe McKinney Muncy

Joe McKinney Muncy Muncy, Geissler, Olds & Lowe PLLC125 S. Royal St.Alexandria, VA 22314United States

Goods and services

ClassDescriptionStatusFirst use
005Biological preparations for the treatment of cancer; Biological tissue cultures for medical purposes; Cellular function activating agents for medical purposes; Diagnostic biomarker reagents for medical purposes; Gases and gas mixtures for medical imaging use; Living cells for medical use; Mixed biological preparations for the prevention and treatment of infectious diseases; Nutritionally fortified water for medical purposes; Nutritive substances for microorganisms for medical purposes; Stem cells for medical purposesACTIVE—
042Biochemical research and analysis; Biological research; Biomedical research services; Medical and scientific research, namely, conducting clinical trials for others; Medical research services in the field of cancer; Pharmaceutical drug development services; Pharmaceutical product evaluation; Research and development services in the field of antibodies; Stem cell research services; Structural and functional analysis of genomesACTIVE—
044Cognitive therapy services; Genetic testing for medical purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical and pharmaceutical consultation; Medical consultations; Medical counseling relating to disease risk; Medical information; Medical services; Performing diagnosis of diseases; Providing medical information; Stem cell therapy servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 8, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 8, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 6, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 11, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 11, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 5, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 14, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 10, 2025DOCKASSIGNED TO EXAMINER—
Feb 9, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 22, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance